- Home
- BHM vs PAVM Comparison
BHM vs PAVM Comparison
Compare BHM & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BHM | PAVM |
|---|---|---|
| Founded | 2022 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.5M | 41.1M |
| IPO Year | 2022 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BHM | PAVM |
|---|---|---|
| Price | $7.93 | $3.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $15.00 | ★ $65.00 |
| AVG Volume (30 Days) | 1.7K | ★ 24.7K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | ★ 4.54% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $68,734,000.00 | $3,000,000.00 |
| Revenue This Year | N/A | $603.94 |
| Revenue Next Year | N/A | $33.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 36.88 | 20.00 |
| 52 Week Low | $8.02 | $0.21 |
| 52 Week High | $13.30 | $28.44 |
Technical Indicators
Market Signals| Indicator | BHM | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 41.09 | 43.60 |
| Support Level | N/A | $3.78 |
| Resistance Level | $8.97 | $6.56 |
| Average True Range (ATR) | 0.23 | 0.37 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 1.90 | 35.62 |
Price Performance
Historical ComparisonAbout BHM Bluerock Homes Trust Inc.
Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.